🟢 Lantern Pharma is trading 7.81% up in after-hours trading as no company-specific catalyst was verified

Lantern Pharma is trading 7.81% higher at $1.30 after hours, with no verified company-specific announcement explaining the rebound.

• Shares closed September 24, 2026, at $1.21 after falling 12.95% in regular trading.
• The latest company communication concerned a September 23 Open-Medicine AI webinar.
• The Nasdaq fell 1.07% and biotechnology ETF XBI declined 2.04%; those moves do not directly explain Lantern Pharma’s opposite-direction after-hours gain.